Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers in vitro and in vivo
- PMID: 35014916
- PMCID: PMC8757603
- DOI: 10.1080/10717544.2021.2023695
Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers in vitro and in vivo
Abstract
Combination therapy combining two drugs in one modified drug delivery system is used to achieve synergistic analgesic effect, and bring effective control of pain management, especially postoperative pain management. In the present study, a combination of drug delivery technologies was utilized. Transcriptional transactivator (TAT) peptide modified, transdermal nanocarriers were designed to co-deliver ropivacaine (RVC) and meloxicam (MLX) and anticipated to achieve longer analgesic effect and lower side effect. TAT modified nanostructured lipid carriers (TAT-NLCs) were used to co-deliver RVC and MLX. RVC and MLX co-loaded TAT-NLCs (TAT-NLCs-RVC/MLX) were evaluated through in vitro skin permeation and in vivo treatment studies. NLCs-RVC/MLX showed uniform and spherical morphology, with a size of 133.4 ± 4.6 nm and a zeta potential of 20.6 ± 1.8 mV. The results illustrated the anesthetic pain relief ability of the present constructed system was significantly improved by the TAT modification through the enhanced skin permeation efficiency and the co-delivery of MLX along with RVC that improved pain management by reducing inflammation at the injured area. This study provides an efficient and facile method for preparing TAT-NLCs-RVC/MLX as a promising system to achieve synergistic analgesic effect.
Keywords: Combination anesthetic; co-delivery; meloxicam; nanostructured lipid carriers; ropivacaine.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures





Similar articles
-
A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine.Drug Des Devel Ther. 2017 Jun 28;11:1941-1949. doi: 10.2147/DDDT.S135916. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28721013 Free PMC article.
-
Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.Drug Des Devel Ther. 2019 Sep 18;13:3307-3319. doi: 10.2147/DDDT.S211443. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31571832 Free PMC article.
-
Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.Drug Deliv. 2016 Nov;23(9):3193-3199. doi: 10.3109/10717544.2016.1160459. Epub 2016 Apr 5. Drug Deliv. 2016. PMID: 27045388
-
Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.Drug Dev Ind Pharm. 2015;41(8):1368-75. doi: 10.3109/03639045.2014.950586. Epub 2014 Aug 25. Drug Dev Ind Pharm. 2015. PMID: 25151872
-
Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.Life Sci. 2013 Nov 13;93(21):763-72. doi: 10.1016/j.lfs.2013.09.027. Epub 2013 Oct 7. Life Sci. 2013. PMID: 24113071
Cited by
-
Topical Administration of Nanostructured Lipid Carriers as a Viable Approach to Reduce Inflammation: A Review.Antiinflamm Antiallergy Agents Med Chem. 2025;24(1):26-42. doi: 10.2174/0118715230311633240708075738. Antiinflamm Antiallergy Agents Med Chem. 2025. PMID: 39082164 Review.
-
Design of Liposomal Lidocaine/Cannabidiol Fixed Combinations for Local Neuropathic Pain Treatment.Pharmaceutics. 2022 Sep 10;14(9):1915. doi: 10.3390/pharmaceutics14091915. Pharmaceutics. 2022. PMID: 36145663 Free PMC article.
-
Strategies for transportation of peptides across the skin for treatment of multiple diseases.Ther Deliv. 2025 Jan;16(1):63-86. doi: 10.1080/20415990.2024.2411943. Epub 2024 Oct 16. Ther Deliv. 2025. PMID: 39411995 Review.
-
Nanomaterial-Based Drug Delivery Systems for Pain Treatment and Relief: From the Delivery of a Single Drug to Co-Delivery of Multiple Therapeutics.Pharmaceutics. 2023 Sep 13;15(9):2309. doi: 10.3390/pharmaceutics15092309. Pharmaceutics. 2023. PMID: 37765278 Free PMC article. Review.
-
Application of Advanced Technologies-Nanotechnology, Genomics Technology, and 3D Printing Technology-In Precision Anesthesia: A Comprehensive Narrative Review.Pharmaceutics. 2023 Sep 6;15(9):2289. doi: 10.3390/pharmaceutics15092289. Pharmaceutics. 2023. PMID: 37765258 Free PMC article. Review.
References
-
- Balocco AL, Van Zundert PGE, Gan SS, et al. (2018). Extended release bupivacaine formulations for postoperative analgesia: an update. Curr Opin Anaesthesiol 31:636–42. - PubMed
-
- de Araújo DR, da Silva DC, Barbosa RM, et al. (2013). Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches. Expert Opin Drug Deliv 10:1551–63. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources